WO2014135511A1 - Appareil pour le traitement temporaire de l'hyperhidrose - Google Patents

Appareil pour le traitement temporaire de l'hyperhidrose Download PDF

Info

Publication number
WO2014135511A1
WO2014135511A1 PCT/EP2014/054113 EP2014054113W WO2014135511A1 WO 2014135511 A1 WO2014135511 A1 WO 2014135511A1 EP 2014054113 W EP2014054113 W EP 2014054113W WO 2014135511 A1 WO2014135511 A1 WO 2014135511A1
Authority
WO
WIPO (PCT)
Prior art keywords
energy
sweat glands
ultrasound
energy source
tissue site
Prior art date
Application number
PCT/EP2014/054113
Other languages
English (en)
Inventor
Afschin Fatemi
Original Assignee
Afschin Fatemi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Afschin Fatemi filed Critical Afschin Fatemi
Publication of WO2014135511A1 publication Critical patent/WO2014135511A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00011—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053—Mechanical features of the instrument of device
    • A61B2018/00059—Material properties
    • A61B2018/00065—Material properties porous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452—Skin
    • A61B2018/00458—Deeper parts of the skin, e.g. treatment of vascular disorders or port wine stains
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00994—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body combining two or more different kinds of non-mechanical energy or combining one or more non-mechanical energies with ultrasound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B2018/1467—Probes or electrodes therefor using more than two electrodes on a single probe
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B2018/147—Electrodes transferring energy by capacitive coupling, i.e. with a dielectricum between electrode and target tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B2018/1472—Probes or electrodes therefor for use with liquid electrolyte, e.g. virtual electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0472—Structure-related aspects
    • A61N1/0492—Patch electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N2007/0004—Applications of ultrasound therapy
    • A61N2007/0034—Skin treatment

Definitions

  • the technology provided herein relates to medical systems, methods novel use of electromagnetic or ultrasound energy for to the temporary treatment of hyperhidrosis.
  • the present application relates to methods and apparatuses for reducing the temporary sweat production via the temporary removal, disablement, incapacitation of apocrine and eccrine glands in the dermal and subcutaneous tissue.
  • Focal hyperhidrosis is an entity, in which patients sweat excessively in selected areas of the body, most commonly axillae, palms or feet. Patients sweat in general more than 30mg/min, independent of external or internal temperatures.
  • Focal hyperhidrosis can be followed by other diseases such as intertrigo, mycosis, bacterial infection, erythema, pigmentation, bromhidrosis, general infection or cold.
  • Treatment options include topical aluminum chloride or iontopheresis, which are both not very effective and are accompanied by discomfort. Same as with not so effective systemic medications, there is an injections of botulinum toxin are effective, but the effect lasts only up to six months.
  • embodiments of this disclosure provide medical electromagnetic energy systems suitable for the temporary reduction of sweating, comprising an electromagnetic energy emitter coupled to an electromagnetic energy source, wherein the electromagnetic energy source delivers thermal energy between 25 and 50 J/cm2 via the electromagnetic energy emitter through the skin surface to a sweat glands containing tissue site, wherein the temperature of the skin surface is less than the temperature of the sweat glands containing tissue site; and the sweat glands are reduced or temporarily inhibited or their innervation is temporarily inhibited.
  • embodiments of this disclosure relate to methods of treating and preventing focal hyperhidrosis which comprise administering to a patient in need of such treatment or prevention electromagnetic energy.
  • embodiments of this disclosure relate to medical ultrasound energy systems suitable for the temporary reduction of sweating, comprising an ultrasound energy emitter coupled to an ultrasound energy source, wherein the ultrasound energy source delivers ultrasound energy between 40 to 60 J/cm2 via the ultrasound energy emitter through the skin surface to a sweat glands containing tissue site, wherein the temperature of the skin surface is less than the temperature of the sweat glands containing tissue site; and the sweat glands are reduced or temporarily inhibited or their innervation is temporarily inhibited.
  • the present disclosure pertains to methods for the noninvasive ly temporary treatment of hyperhidrosis and/or normohydrosis by exposing an area of skin tissue comprising a layer of sweat glands to an electromagnetic energy, whereby the electromagnetic energy is delivered from an electromagnetic energy source through the skin surface to the sweat glands containing tissue site, and wherein the temperature of the skin surface is less than the temperature of the sweat glands containing tissue site during the treatment; and the sweat glands are reduced or temporarily inhibited or their innervation is temporarily inhibited.
  • the present disclosure pertains to methods for the noninvasive ly temporary treatment of hyperhidrosis and/or normohydrosis by exposing an area of skin tissue comprising a layer of sweat glands to an ultrasound energy, whereby the ultrasound energy is delivered from an ultrasound energy source through the skin surface to the sweat glands containing tissue site, and wherein the temperature of the skin surface is less than the temperature of the sweat glands containing tissue site during the treatment; and the sweat glands are reduced or temporarily inhibited or their innervation is temporarily inhibited.
  • the present disclosure pertains to uses of electromagnetic or ultrasound energy for the temporary reduction of sweat glands, wherein: a) an electromagnetic or ultrasound energy source is provided;
  • the present disclosure pertains also to methods for reducing sweat glands in a selected sweat glands containing tissue site beneath an epidermis skin surface, comprising: a) providing an electromagnetic or ultrasound energy source with an energy delivery surface; b) positioning the energy delivery surface on the epidermis skin surface; c) creating an uniform reverse thermal gradient through the skin epidermis surface where a temperature of the skin epidermis surface is lower than the selected sweat glands containing tissue site; and d) delivering energy from the energy source through the skin epidermis surface to the selected sweat glands containing tissue site for a sufficient time to reduce a plurality of sweat glands in the selected sweat glands containing tissue site.
  • FIG. 1 is a perspective view of an example of an apparatus for applying electromagnetic energy through the skin in order to cause a reduction of sweat glands.
  • nerval pulses or glands are inhibited and/or parts of nerves, ducts or glands are denaturized. All these effects are mostly temporary.
  • the treatment is a low-risk procedure and can be done with a home-use device without supervision of a doctor or medical professional.
  • the amount of energy transferred via ultrasound may be between 40 to 60 J/cm 2 , in particular between 45 to 55 J/cm 2 , more particular 47 J/cm 2 , the electromagnetic energy transferred to the area of need is between 25 and 50 J/cm 2 , in particular between 30 to 40 J/cm 2 , more particular 35 J/cm 2 .
  • the present disclosure provides methods for temporary reducing sweat glands e.g. for the temporary treatment of hyperhidrosis below a tissue surface in a selected tissue site.
  • the reduction or elimination of sweat glands can be done preferably transcutaneously, with a uniform reverse thermal gradient, percutaneously, transmucosally, permucosally, or through a device including but not limited to an endoscope.
  • An electromagnetic or ultrasound energy apparatus is provided and includes an electromagnetic or ultrasound energy source and a delivery device. The delivery device is positioned on the tissue surface. Low electromagnetic or ultrasound energy is produced from the electromagnetic or ultrasound energy source and delivered through the tissue surface to the selected tissue site for a sufficient time to temporary reduce sweat glands in the selected tissue site. No burn is formed on the tissue surface. This method is particularly useful with a home-use device without supervision of a doctor or other medical professional.
  • Hyperhidrosis can either be generalized or localized to specific parts of the body. Hands, feet, armpits, and the groin area are among the most active regions of perspiration due to the relatively high concentration of sweat glands; however, any part of the body may be affected. Hyperhidrosis can also be classified depending by onset, congenital or acquired. Primary hyperhidrosis is found to start during adolescence or even before and seems to be inherited as an autosomal dominant genetic trait.
  • Primary hyperhidrosis must be distinguished from secondary hyperhidrosis, which can start at any point in life.
  • the latter form may be due to a disorder of the thyroid or pituitary gland, diabetes mellitus, tumors, gout, menopause, certain drugs, or mercury poisoning.
  • Hyperhidrosis may be also divided into palmoplantar (symptomatic sweating of primarily the hands or feet), gustatory and generalized hyperhidrosis. Alternatively, hyperhidrosis may be classified according to the amount of skin that is affected and its possible causes.
  • the methods of the present disclosure use an electromagnetic or ultrasound energy source to apply electromagnetic or ultrasound energy to a selected tissue site.
  • the electromagnetic or ultrasound energy can be delivered transcutaneously, with a reverse thermal gradient, percutaneously, transmucosally, permucosally, or through a device including but not limited to an endoscope.
  • the methods of the present invention provide for the reduction of sweat glands underlying a tissue surface area.
  • the overlying layer of tissue is not ablated. No deeper than a second degree burn is produced in the overlying layer of tissue, and preferably no deeper than a first degree burn.
  • Suitable applications for the methods of the present disclosure include but are not limited to the treatment of sweating due to hyperhidrosis, normohydrosis bromhidrosis, hidradenitis suppurativa, hypohidrotic ectodermal dysplasia, hypotrichosis, anodontia, hypohidrosis, hidrotic ectodermal dysplasia, uremic frost, neoplasms, syringomata, and various forms of miliarias.
  • the methods according to the present disclosure are useful for the treatment sweating due to hyperhidrosis, in particular due to Hyperhidrosis axillaris and Hyperhidrosis palmaris.
  • an apparatus is used to create the uniform reverse thermal gradient is a composite heating pad that has both cooling elements and electromagnetic delivery devices.
  • the heating pad is configured to the topography of the treatment area and is incorporated into an elastic garment. Partial reduction of sweat glands is achieved with each treatment. Thermal transducers measure the surface temperature of the treatment area to avoid blistering. In one embodiment the deeper dermis is heated to above 65 degrees for sweat glands destruction. Sequential treatments are designed to allow for more precision of the end result. Areas of application are not confined by requirements to either hide surgical incisions or transition along aesthetic boundaries.
  • the radiofrequency treatment according to the present disclosure delivers almost uniform and deep heating since only with almost uniform and deep heating it is possible to coagulate enough sweat glands to treat hyperhidrosis effectively.
  • a uniform reverse thermal gradient means that the energy delivery surface uniformly distributes the thermal gradient through the skin epidermis surface to the selected sweat glands containing tissue site.
  • Electromagnetic energy may be any kind that can cause cell heating or physical destruction by being applied to collagen tissue.
  • FIG. 1 shows an example of an apparatus 10 applies electromagnetic energy through a skin layer 12, such as the epidermis, and to the underlying sweat glands tissue 14 without substantially modifying melanocytes and other epithelial cells 16 found in the lower layer of epidermis layer 12.
  • a porous membrane 18 is adapted to receive an electrolytic solution 20.
  • Porous membrane 18 becomes inflated to substantially conform a contacting exterior surface 22 of porous membrane 18 which is in close thermal contact with epidermis 12.
  • Porous membrane 18 includes a cooling lumen 24 for receiving a cooling fluid that imparts a cooling effect on epidermis layer 12.
  • One or more electromagnetic electrodes 26 are positioned at various places in porous membrane 18. In one embodiment, electromagnetic electrodes 26 are positioned on a side that is substantially opposing to contacting exterior surface 22. In other embodiments, electromagnetic electrodes 26 are placed closer to cooling lumen 24. In embodiment particularly suitable for the hips, porous membrane is about 20 cm by 30 cm, with an oval shape. [0035] An electromagnetic power source 28 is coupled to electromagnetic electrodes 26 and a source of electrolytic solution 30 is coupled to porous membrane 18.
  • sweat glands tissue in a dermis underlying the epidermis of the skin is transcutaneous contracted with the use of a thermal heating apparatus.
  • Electromagnetic energy is transcutaneous delivered through the epidermis to the underlying dermis.
  • the method comprises the use of an ultrasound energy system - in particular, a system with a plurality of independently controlled multiple beam transducer elements that are capable of being focused at the treatment depths below the skin surface.
  • an apparatus comprising an ultrasounbd energy source is the Liposonix® device or any similar devices.
  • the severity of the symptoms of focal hyperhidrosis can be temporarily reduced.
  • the severity of excessive sweating or other fluid weeping from the skin, erythematous, leathery appearance and texture, and associated pain and discomfort can be reduced.
  • the methods and uses involve non-invasively treating the affected area with one of the mentioned devices, a gel sheet and a transducer, generally penetrating the skin deeply and creating a lesion in the target area.
  • the methods and uses involves at least one or two such applications separated by two to six, and preferably four week intervals.
  • the Liposonix® system was used for the treatment of hyperhidrosis.
  • the Liposonix® system is used in the prior art to apply high intense focused ultrasound to create heat and shear forces, to destroy target structures in the subcutaneous fat, adipocytes, to achieve nonsurgical body sculpting effects. The lesions induce a wound healing effect, macrophages and other cells clear up the cellular debris of disrupted adipocytes, thus leading to volume loss.
  • the ultrasound device is used with a specific transducer and a gel sheet.
  • the device is used for the treatment and then waiting two to six, and most preferably four, weeks after the first treatment, and then repeating this process one or more times if necessary.
  • one such ultrasound exposure penetrates the diseased tissue and is absorbed by at least some sweat glands. These sweat glands are then disrupted and then resorbed.
  • the present disclosure relates to the treatment of sweating due to hyperhidrosis like focal hyperhidrosis with low radiofrequenncy (RF) energy.
  • RF radiofrequenncy
  • apparatuses and/or systems were used for applying nonablative capacitive radiofrequency energy.
  • capacitive radiofrequency energy and surface cooling are applied by use of the Thermacool® TC3 or NXT or CPT from Solta Medical, Inc., 25881 Industrial Boulevard Hayward, CA 94545, USA or any similar devices.
  • the radiofrequency energy device is used with an electrode comprising specific treatment tips.
  • the specific treatment tips can be internally and/or externally cooled.
  • TC3 or NXT or CPT was used in the treatment.
  • the uses and/or the methods comprises radiation exposure involving treating the diseased tissues with a capacitive, nonablative radiofrequency device such as Thermacool TC3 or NXT or CPT with a specific treatment tip with surface cooling.
  • a capacitive, nonablative radiofrequency device such as Thermacool TC3 or NXT or CPT with a specific treatment tip with surface cooling.
  • local anesthetic cream or injection or block may be applied before the treatment.
  • intravenous deep sedation or anesthesia may be used.
  • radiofrequency exposure penetrates the diseased tissue and is absorbed by at least some sweat glands. These sweat glands are then heated and destroyed.
  • Standard thermal gradient is the thermal content of tissue that is greater on the skin surface.
  • Reverse thermal gradient is, (i) the application of electromagnetic energy to alter the biophysical properties of sweat glands, i.e., reduction, with minimal blistering of the tissue surface, (ii) a gradient in which the tissue surface temperature is cooler than the underlying sweat glands comprising tissue, (iii) conditions in which a standard thermal gradient is reduced or equalized in temperature between the tissue surface and the underlying sweat glands, or (iv) monitoring the heat content (temperature and exposure duration) of the tissue surface to avoid blistering during treatment, regardless of the tissue surface temperature relative to the underlying sweat glands tissue.
  • Transcutaneously means that the delivery device delivers electromagnetic energy directly through the tissue surface.
  • "Sweat glands” are small tubular structures of the skin that produce sweat including eccrine sweat glands which can be distributed all over the body although their density varies from region to region and apocrine sweat glands. In advantageous embodiments, the eccrine sweat glands are reduced by the methods according to the present disclosure.
  • Low energy according to the present disclosure means in advantageous embodiments energy levels delivered to the skin surface below 100 J/cm2.
  • a hand wand is used for the temporary treatment of hyperhidrosis according to the present disclosure, wherein the wand comprises: a first controlling device operably controlling an ultrasonic imaging function for providing ultrasonic imaging; a second controlling device operably controlling an ultrasonic treatment function for providing ultrasonic treatment; a movement mechanism configured to direct ultrasonic treatment in a linear sequence of individual thermal lesions; and at least a first and a second removable transducer module, wherein said first and second transducer modules are configured for both ultrasonic imaging and ultrasonic treatment, wherein said first and second transducer modules are configured for interchangeable coupling to the hand wand, wherein said first transducer module is configured to apply ultrasonic therapy to a first layer of tissue, wherein said second transducer module is configured to apply ultrasonic therapy to a second layer of tissue, wherein the second layer of tissue is at a different depth than the first layer of tissue, and wherein said first and second transducer modules are configured to be operably coupled to at least
  • a hand wand is used for the treatment of hyperhidrosis according to the present disclosure.
  • the hand wand comprises a first controlling device, a second controlling device, a movement mechanism, and a transducer module.
  • the first controlling device operably controls an ultrasonic imaging function for providing ultrasonic imaging.
  • the second controlling device operably controls an ultrasonic treatment function for providing ultrasonic treatment.
  • the movement mechanism is configured to direct ultrasonic treatment in a sequence of individual thepnal lesions.
  • the removable transducer module is configured for both ultrasonic imaging and ultrasonic treatment.
  • the removable transducer module is configured for interchangeable coupling to the hand wand.
  • the removable transducer module is configured to be operably coupled to at least one of said first controlling device, said second controlling device and said movement mechanism.
  • the removable transducer module is configured to apply ultrasonic therapy to at a first variable ultrasonic parameter to tissue.
  • Patient 1 was 26yrs and diagnosed with Hyperhidrosis axillaris. The disease started at the age of 14yrs and never stopped. Iontopheresis or systemic therapy was not sufficient. Gravimetry showed excessive sweating of 141mg/min on the right side and 149mg/min on the left side. The patient also suffered from discomfort in the diseased area, Mycosis appeared. [0071] The patient's hyperhidrosis condition was stable but included the significant problematic symptoms noted above.
  • the patient's axillae were treated with the Liposonix® device and a gel sheet, applying ultrasound to this patient with certain appropriate energy levels and penetration depths and appropriate number of pulses and passes.
  • Patient 2 was 31yrs and, through steps one and two, diagnosed with
  • Hyperhidrosis palmaris The disease started at the age of 16yrs and never stopped. Iontopheresis or AlCl was not sufficient. Gravimetry showed excessive sweating of 86mg/min on the right side and 72mg/min on the left side. The patient also suffered from discomfort in the diseased area.
  • Patient 3 was 37yrs and diagnosed with Hyperhidrosis axillaris. The disease started at the age of 15yrs and never stopped. AlCl and iontopheresis were not sufficient. Gravimetry showed excessive sweating of 161mg/min on the right side and 186mg/min on the left side. The patient also suffered from discomfort and temporary mycosis in the diseased area.
  • the patient's feet were treated with ultrasound of Ulthera® with the appropriate energy levels and appropriate penetration depths and appropriate number of pulses and passes, with a waiting time of three days before repeating the treatment a second and a third time.
  • this ultrasound energy either heats and partially disrupts the target structures, such as sweat glands, while other structures such as epidermis superficial to the target or other structures deeper to the target are protected, or it just paralyses the sweat glands or their innervation.
  • This treatment can be done at home or any other institution, preferably with a handheld device. It is pain-free and low risk, it can therefore be done without a doctor's supervision.
  • Patient 4 was 42yrs and diagnosed with Hyperhidrosis axillaris. The disease started at the age of 14yrs and never stopped. AlCl was not sufficient. Gravimetry showed excessive sweating of 221mg/min on the right side and 201mg/min on the left side. The patient also suffered from discomfort in the diseased area.
  • the patient's axillae were treated with non ablative capacitive radiofrequency radiation to this patient with the appropriate energy levels and appropriate number of pulses, while cooling the skin during the pulse.
  • the treatment was repeated one day and two days after the first procedure.
  • Patient 5 was 35yrs and diagnosed with Hyperhidrosis palmaris. The disease started at the age of 18yrs and never stopped. Iontopheresis was not sufficient. Gravimetry showed excessive sweating of 125mg/min on the right side and 180mg/min on the left side. The patient also suffered from erythema and discomfort in the diseased area.
  • Patient 6 was 45yrs and diagnosed with Hyperhidrosis axillaris. The disease started at the age of 16yrs and never stopped. AlCl was not sufficient, Btx was effective for 5mths. Mycosis appeared. Gravimetry showed excessive sweating of 169mg/min on the right side and 206mg/min on the left side. The patient also suffered from discomfort in the diseased area.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Surgery (AREA)
  • Plasma & Fusion (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Otolaryngology (AREA)
  • Percussion Or Vibration Massage (AREA)

Abstract

La présente invention concerne des systèmes médicaux, des procédés et une nouvelle utilisation de l'énergie électromagnétique ou ultrasonore pour le traitement temporaire de l'hyperhidrose. En particulier, la présente demande concerne des procédés et des appareils pour réduire la production de transpiration temporaire via la suppression, l'inactivation, l'invalidation temporaire des glandes apocrines et eccrines du derme et du tissu sous-cutané.
PCT/EP2014/054113 2013-03-04 2014-03-04 Appareil pour le traitement temporaire de l'hyperhidrose WO2014135511A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13157654 2013-03-04
EP13157654.8 2013-03-04

Publications (1)

Publication Number Publication Date
WO2014135511A1 true WO2014135511A1 (fr) 2014-09-12

Family

ID=47826979

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2014/054113 WO2014135511A1 (fr) 2013-03-04 2014-03-04 Appareil pour le traitement temporaire de l'hyperhidrose

Country Status (1)

Country Link
WO (1) WO2014135511A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102015000150A1 (de) * 2015-01-03 2016-07-07 Lenicura Gmbh Vorrichtung und/oder Methode zur Behandlung von Hidradenitis suppurativa

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241753B1 (en) 1995-05-05 2001-06-05 Thermage, Inc. Method for scar collagen formation and contraction
US6311090B1 (en) 1995-05-05 2001-10-30 Thermage, Inc. Method and apparatus for controlled contraction of collagen tissue
US6350276B1 (en) 1996-01-05 2002-02-26 Thermage, Inc. Tissue remodeling apparatus containing cooling fluid
US6387380B1 (en) 1995-05-05 2002-05-14 Thermage, Inc. Apparatus for controlled contraction of collagen tissue
US6425912B1 (en) 1995-05-05 2002-07-30 Thermage, Inc. Method and apparatus for modifying skin surface and soft tissue structure
US7022121B2 (en) 1999-03-09 2006-04-04 Thermage, Inc. Handpiece for treatment of tissue
WO2006089227A2 (fr) * 2005-02-18 2006-08-24 Palomar Medical Technologies, Inc. Dispositif de traitement dermatologique
WO2007015247A2 (fr) * 2005-08-04 2007-02-08 Inolase 2002 Ltd. Procede et appareil destines a inhiber des signaux de douleur durant des traitements medicaux de la peau assistes par depression
US7258674B2 (en) 2002-02-20 2007-08-21 Liposonix, Inc. Ultrasonic treatment and imaging of adipose tissue
WO2009149390A1 (fr) 2008-06-06 2009-12-10 Ulthera, Inc. Système et procédé de traitement cosmétique et d'imagerie
WO2009147617A1 (fr) * 2008-06-02 2009-12-10 L'oreal Procédé d'atténuation de la transpiration
WO2012072250A1 (fr) * 2010-11-30 2012-06-07 Afschin Fatemi Appareil pour le traitement de l'hyperhidrose

Patent Citations (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6425912B1 (en) 1995-05-05 2002-07-30 Thermage, Inc. Method and apparatus for modifying skin surface and soft tissue structure
US6311090B1 (en) 1995-05-05 2001-10-30 Thermage, Inc. Method and apparatus for controlled contraction of collagen tissue
US6453202B1 (en) 1995-05-05 2002-09-17 Thermage, Inc. Method and apparatus for controlled contraction of collagen tissue
US6241753B1 (en) 1995-05-05 2001-06-05 Thermage, Inc. Method for scar collagen formation and contraction
US6381498B1 (en) 1995-05-05 2002-04-30 Thermage, Inc. Method and apparatus for controlled contraction of collagen tissue
US6381497B1 (en) 1995-05-05 2002-04-30 Thermage, Inc. Method for smoothing contour irregularity of skin surface by controlled contraction of collagen tissue
US6387380B1 (en) 1995-05-05 2002-05-14 Thermage, Inc. Apparatus for controlled contraction of collagen tissue
US6405090B1 (en) 1995-05-05 2002-06-11 Thermage, Inc. Method and apparatus for tightening skin by controlled contraction of collagen tissue
US6377855B1 (en) 1995-05-05 2002-04-23 Thermage, Inc. Method and apparatus for controlled contraction of collagen tissue
US6350276B1 (en) 1996-01-05 2002-02-26 Thermage, Inc. Tissue remodeling apparatus containing cooling fluid
US7022121B2 (en) 1999-03-09 2006-04-04 Thermage, Inc. Handpiece for treatment of tissue
US7258674B2 (en) 2002-02-20 2007-08-21 Liposonix, Inc. Ultrasonic treatment and imaging of adipose tissue
US7841984B2 (en) 2002-02-20 2010-11-30 Medicis Technologies Corporation Ultrasonic treatment and imaging of adipose tissue
WO2006089227A2 (fr) * 2005-02-18 2006-08-24 Palomar Medical Technologies, Inc. Dispositif de traitement dermatologique
WO2007015247A2 (fr) * 2005-08-04 2007-02-08 Inolase 2002 Ltd. Procede et appareil destines a inhiber des signaux de douleur durant des traitements medicaux de la peau assistes par depression
WO2009147617A1 (fr) * 2008-06-02 2009-12-10 L'oreal Procédé d'atténuation de la transpiration
WO2009149390A1 (fr) 2008-06-06 2009-12-10 Ulthera, Inc. Système et procédé de traitement cosmétique et d'imagerie
WO2012072250A1 (fr) * 2010-11-30 2012-06-07 Afschin Fatemi Appareil pour le traitement de l'hyperhidrose

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102015000150A1 (de) * 2015-01-03 2016-07-07 Lenicura Gmbh Vorrichtung und/oder Methode zur Behandlung von Hidradenitis suppurativa
EP3240610A1 (fr) * 2015-01-03 2017-11-08 Lenicura GmbH Dispositif et/ou méthode pour traiter les maladies de peau, des glandes, des muqueuses, du tissu conjonctif, des nerfs et/ou du tissu cérébral
DE102015000150B4 (de) * 2015-01-03 2019-11-21 Lenicura Gmbh Vorrichtung zur Behandlung von Hidradenitis suppurativa
US11497553B2 (en) 2015-01-03 2022-11-15 Lenicura Gmbh Device and/or method for treating diseases of the skin, glands, mucosae, connective tissue, nerves and/or horny tissue

Similar Documents

Publication Publication Date Title
US9149650B2 (en) Non-invasive method for slimming a human body using laser energy of wavelengths shorter than 632 nm
Sukal et al. Thermage: the nonablative radiofrequency for rejuvenation
Jacob Treatment of hyperhidrosis with microwave technology
KR20120090007A (ko) 경피적으로 에너지를 전달하는 장치 및 방법
US20130310715A1 (en) Apparatus for the treatment of hyperhidrosis
Görgü et al. Radiofrequency: review of literature
Lee et al. Updates on radiofrequency devices for skin tightening and body contouring
EP3634290B1 (fr) Système pour réduction de l'adiposité et amélioration du relâchement cutané
Murgia et al. Body contouring for fat and muscle in aesthetics: review and debate
RU2451531C1 (ru) Способ лечения базально-клеточного рака кожи
Braden McKnight et al. Improving upper arm skin laxity using a tripollar radiofrequency device
Lukac et al. TightSculpting®: A complete minimally invasive body contouring solution; Part II: Tightening with FotonaSmooth® technology
WO2014135511A1 (fr) Appareil pour le traitement temporaire de l'hyperhidrose
Cho et al. High-frequency alternating electrical current: selective electromagnetic tissue reaction
Al_Dulamey The Development of microwave applications in medical field
Fritz et al. Energy-based devices: Radiofrequency and high-intensity focused ultrasound
Bogle Radiofrequency energy and hybrid devices
Hong et al. Noninvasive size reduction of lipoma with an insulated monopolar radiofrequency microneedle device.
Khanna et al. Enhanced lipocontouring of the arms
Cho et al. Improvement of periorbital wrinkles treated with an invasive non-insulated microneedle pulsed electric signal device
WO2001032091A2 (fr) Suppression non invasive de tissus adipeux par chauffage controle
Park et al. Clinical study of facial wrinkle treatment with fractional microneedle radio frequency system
Mehta Non-Light Energy-Based Devices
Kaminer et al. Nonsurgical skin tightening
Mazloom et al. Efficacy of radiofrequency technology in the treatment of aesthetic indications

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14711460

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14711460

Country of ref document: EP

Kind code of ref document: A1